Hepatitis C virus infection in the renal transplant recipient

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 8, 2000, Pages 60-64

  First, M Roy ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; RIBAVIRIN; VIRUS RNA;

ARTICLE; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIALYSIS; DISEASE TRANSMISSION; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

EID: 0034487571     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_8.60     Document Type: Article

References (30)

1. Progress in renal transplantation. A single center study of 3359 patients over 25 years
2. Long-term results and complications in renal transplant recipients: Observations in the second decade
3. Donor hepatitis C virus status does not adversely effect short-term outcome in HCV + recipients in renal transplantation
4. Transmission of hepatitis C virus by organ transplantation
5. Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients
6. Non-A, non-B hepatitis and elevated serum amino-transferases in renal transplant patients
7. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission
8. Incident and risk factors for hepatitis C virus sera conversion in hemodialysis. A prospective study
9. Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance hemodialysis
10. Impact of hepatitis B and C virus on kidney transplantation outcome
11. Hepatitis C virus infection among kidney transplant recipients
12. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation
13. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients
14. The impact of hepatitis C virus infection in renal allograft recipients
15. The impact of pretransplant hepatitis C infection on the outcome of renal transplantation
16. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplant anti-HCV
17. Long-term follow-up of hepatitis C virus infection among organ transplant recipients
18. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients
19. Impact of hepatitis on transplantation
20. Hepatitis C virus: The nephrologist's view
21. Increased susceptibility for CSA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis
22. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients
23. Effect of hepatitis C infection in renal transplantation on survival in end-stage renal disease
24. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients
25. Comparison of survival probabilities for dialysis patients versus cadaveric renal transplant recipients
26. High risk of hepatitis C virus clearance in hemodialysis patients after interferon-gamma therapy
27. Combination of interferon alpha and ribavirin in the treatment of hepatitis C: Implications for the clinical nephrologist
28. Outbreaks of hepatitis B virus infection among hemodialysis patients-California, Nebraska, and Texas, 1994
29. Preventing hepatitis B and hepatitis C infections in end-stage renal disease patients
30. Recommendations for prevention and control of hepatitis C virus (HCV infection) and HCV-related chronic disease